Developer docs
API playgroundTry for free, no card

Search company profiles

Carlsbad Technology

Full company profile

uuid000pnz3

Namestring
Carlsbad Technology
Legal namestring
Carlsbad Technology, Inc.
Company typeenum
Private
Founded yearint
1990
Descriptiontext

Carlsbad Technology, Inc. is a Carlsbad, California-headquartered generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor that has operated continuously since 1990. The company manufactures a portfolio of generic oral solid-dose drugs—including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine—and distributes through direct sales to wholesalers, distributors, managed care accounts, and retail pharmacies across all 50 U.S. states and Puerto Rico. Carlsbad Technology is a privately held subsidiary of the Taiwan-based YungShin Group, which the company cites as the source of a stated "bridge" between Asian and Americas pharmaceutical markets.

The company's technical footprint centers on a single California campus featuring an FDA-approved, cGMP-compliant manufacturing facility with state-of-the-art equipment controlling production from raw ingredient to finished product. Supporting infrastructure includes temperature- and air-controlled rack storage, a cGMP-compliant sampling booth, restricted quarantine areas for non-conforming materials and returned products, and a warehouse management system (WMS) for inventory and order fulfillment. Carlsbad Technology holds multiple regulatory credentials: cGMP validation achieved in 1998, FDA approval of its manufacturing facility, VAWD (Verified-Accredited Wholesale Distributors) accreditation from the National Association of Boards of Pharmacy recognized in 21 states, and NABD accreditation. Its first ANDA approval was for Diclofenac Sodium Delayed Release Tablets in 1998.

Carlsbad Technology operates three revenue streams: (1) branded-generic pharmaceutical product sales across multiple therapeutic categories, sold on a quote-based, non-publicly-disclosed pricing basis; (2) regulatory advisory services spanning ANDA/DMF submissions, OTC monograph applications, prescription-to-OTC switches, 510(k)/PMA/IDE medical device pathways, dietary supplement NDI/GRAS approvals, and pharmacovigilance; and (3) contract manufacturing, packaging, and warehousing services for third-party partners leveraging its cGMP facility and temperature-controlled logistics. The go-to-market relies on direct enterprise sales supported by website, trade publication, and industry-event presence. Regulatory advisory functions both as a discrete revenue line and as a capability that supports entry of partners' products into the U.S. market.

Short descriptiontext

Carlsbad Technology is a Carlsbad, California-based generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor serving wholesalers, managed care accounts, and retail pharmacies nationwide. Founded in 1990, it operates as part of Taiwan's YungShin Group with cGMP-compliant, VAWD-accredited facilities.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCarlsbad, United States
HQ citystring
Carlsbad
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceutical manufacturing, FDA regulatory consulting, cGMP compliant production, pharmaceutical wholesale distribution, ANDA drug approval services
Industry3 codes
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRAOAHAB
OTC Medicines & Consumer Health Products Distribution
SECONDARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
NAICS code3 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing32541
SIC code3 codes
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Generic Pharmaceuticals
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Generic Pharmaceutical Product Sales
TypeOne Time License
Description

Manufacturing and selling generic pharmaceutical drugs including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in various dosages and packaging configurations.

carlsbadtech.com
2Regulatory Advisory Services
TypeProfessional Services
Description

FDA consulting services including drug approval consultations, regulatory submissions, compliance support, and US agent services for pharmaceutical, diagnostic, biotech, and medical device companies.

carlsbadtech.com
3Contract Manufacturing
TypeProfessional Services
Description

Contract manufacturing services for generic pharmaceuticals and OTC products with cGMP-compliant facilities.

carlsbadtech.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Generic pharmaceutical products - quote-based pricing
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing not publicly disclosed; direct contact required for product quotes and ordering.

carlsbadtech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Carlsbad Technology manufactures, packages, and distributes a portfolio of generic pharmaceutical drugs (capsules and tablets such as Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine) from its cGMP-compliant, FDA-approved facility in Carlsbad, California. The company also offers contract manufacturing for generic and OTC products, VAWD-accredited wholesale distribution with temperature-controlled warehousing, and FDA regulatory advisory/consulting services covering ANDA submissions, OTC monographs, medical devices, and dietary supplements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • cGMP validation achieved in 1998, demonstrating long-term compliance capability
+2 more records
Product overview1 text field

Carlsbad Technology is a generic pharmaceutical company offering a comprehensive portfolio of generic drugs and pharmaceutical services. The core product is their Generic Pharmaceuticals line including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in various strengths and packaging sizes. The company operates FDA-approved, cGMP-compliant manufacturing facilities and provides regulatory advisory services spanning drug approval consulting, OTC drug advisory, medical device regulatory services, dietary/health supplement approval, and pharmaceutical packaging. Additional services include VAWD-accredited wholesale distribution, warehousing with temperature control and WMS systems, and sales/marketing across all 50 U.S. states and Puerto Rico. The company entered the U.S. generic pharmaceutical market in 1990, with their first ANDA approved in 1998 for Diclofenac Sodium Delayed Release Tablets.

Product and service11 records
1Generic Pharmaceuticals (capsules and tablets)
CategoryGeneric Pharmaceuticals
Description

A portfolio of generic pharmaceutical drugs including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in capsules and tablets across multiple therapeutic categories (anti-infectives, anti-inflammatories, cardiovascular, neurological).

2FDA Approved Contract Manufacturing
CategoryPharmaceutical Contract Manufacturing
Description

Contract manufacturing services using a cGMP-compliant, FDA-approved California facility with state-of-the-art equipment for generic and OTC pharmaceutical production, with rigorous raw material inspection and quality control throughout the manufacturing cycle.

3FDA Drug Approval Consulting
CategoryRegulatory Advisory Services
Description

Consulting services for pharmaceutical, diagnostics, biotech, and medical device companies covering ANDA submissions, Drug Master File (DMF) submissions, FDA meeting support, cGMP compliance, and US agent services.

4FDA OTC Drug Approval Consulting
CategoryRegulatory Advisory Services
Description

Consulting for over-the-counter drug approval including OTC drug monograph applications, prescription-to-OTC switch applications, and Time and Extent Application (TEA) preparation for OTC Drug Monograph amendments.

5FDA Medical Devices Regulatory Advisory
CategoryRegulatory Advisory Services
Description

Regulatory advisory for medical devices covering 510(k) Premarket Notifications, Investigational New Drug Applications (INDs), Investigational Device Exemption Applications (IDEs), Premarket Approval Applications (PMAs), Biologic License Applications (BLA), and 513(g) Requests for Classification.

6FDA Dietary Supplement Approval Consulting
CategoryRegulatory Advisory Services
Description

Regulatory consulting for dietary supplements including New Dietary Ingredient (NDI) notifications, GRAS (Generally Recognized as Safe) supplement approvals, regulatory label services, and FDA compliance.

7FDA Health Supplement Approval Regulatory Advisory
CategoryRegulatory Advisory Services
Description

Regulatory advisory for health supplements including GMP compliance and audits, label review, cGMP compliance, clinical trials, NDI notifications, documentation, recall assistance, and quality systems.

8Generic Pharmaceutical Drug Packaging
CategoryPharmaceutical Manufacturing Services
Description

Drug packaging and repackaging services ensuring compliance with FDA guidelines for labeling, container closure, product identity, quality, purity, and contamination prevention, including child-resistant features.

9Warehousing & Distribution
CategoryPharmaceutical Distribution & Logistics
Description

Temperature-controlled warehouse storage with cGMP-compliant sampling booth and quarantine area, utilizing a Warehouse Management System (WMS) for inventory tracking, order fulfillment, and pharmaceutical supply chain management, supporting ambient, hazardous, and refrigerated conditions.

10VAWD-Accredited Wholesale Distribution
CategoryPharmaceutical Distribution & Logistics
Description

Verified-Accredited Wholesale Distributors (VAWD) certified wholesale distribution recognized by 21 U.S. states, ensuring compliance with state and federal laws for distributing prescription drugs from manufacturers to pharmacies.

11Pharmaceutical Sales & Marketing
CategoryPharmaceutical Distribution & Logistics
Description

Sales and marketing of generic pharmaceuticals across all 50 U.S. states and Puerto Rico, with capability to partner with contract developers and manufacturers to market their products.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1YungShin Group
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Carlsbad Technology, Inc. is part of the worldwide YungShin Group, which provides strength, commitment to innovation, and pursuit of providing the best medicines to enhance human health. YungShin represents world-class quality standards.

carlsbadtech.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

India-headquartered global pharmaceutical company with a substantial U.S. generics business. Comparable in cross-border generics supply chain and FDA-approved manufacturing footprint, though materially larger and broader in API and finished dosage portfolio.

2Endo International
TypeBroad incumbent
Description

Specialty and generic pharmaceutical manufacturer with a portfolio spanning sterile injectables, generic solids, and branded specialty. A broader incumbent versus Carlsbad Tech, with overlapping generics distribution but a substantially wider therapeutic footprint.

TypeDirect peer
Description

India-based global generic pharmaceutical manufacturer with a large U.S. subsidiary (Aurobindo Pharma USA) and FDA-approved manufacturing facilities. Comparable to Carlsbad Tech through its foreign-parent-backed U.S. generics distribution model and ANDA-heavy portfolio.

TypeDirect peer
Description

India-headquartered generic pharmaceutical company with a U.S. presence (Glenmark Pharmaceuticals Inc., USA). Comparable to Carlsbad Tech as a foreign-owned, U.S.-distributed generic manufacturer serving wholesalers and managed care accounts.

TypeDirect peer
Description

Canadian-headquartered generic pharmaceutical manufacturer with significant U.S. distribution and a broad ANDA portfolio. Comparable to Carlsbad Tech in generic manufacturing, FDA-approved facility profile, and cross-border supply chain orientation.

TypeDirect peer
Description

Mid-sized U.S. generic pharmaceutical manufacturer with both branded specialty and generic product lines. Comparable to Carlsbad Tech in target customers, therapeutic categories (cardiovascular, CNS), and contract manufacturing/distribution capabilities.

7Sandoz
TypeBroad incumbent
Description

Novartis's generic pharmaceutical division with global manufacturing and U.S. distribution. A broad incumbent competing head-to-head with Carlsbad Tech across generic solid orals, injectables, and biosimilars, but at a vastly larger scale.

TypeDirect peer
Description

U.S. generic drug manufacturer with a portfolio spanning solid oral, topical, and specialty generics. Comparable to Carlsbad Tech in business model (generic manufacturer/distributor) and competitive positioning as a smaller U.S. generics player.

TypeBroad incumbent
Description

World's largest generic pharmaceutical manufacturer with extensive U.S. operations and a broad ANDA portfolio across most therapeutic categories. Comparable as a competitor in the same generic categories Carlsbad Tech serves, but at vastly greater scale and portfolio breadth.

TypeDirect peer
Description

U.S.-focused generic and specialty pharmaceutical manufacturer with an integrated manufacturing and distribution model. Closely comparable to Carlsbad Tech in product mix, ANDA strategy, and mid-tier scale, but materially larger in headcount and portfolio breadth.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Carlsbad Technology

Generic Pharmaceuticalscarlsbadtech.com

Carlsbad Technology is a Carlsbad, California-based generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor serving wholesalers, managed care accounts, and retail pharmacies nationwide. Founded in 1990, it operates as part of Taiwan's YungShin Group with cGMP-compliant, VAWD-accredited facilities.

What Carlsbad Technology does

Carlsbad Technology, Inc. is a Carlsbad, California-headquartered generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor that has operated continuously since 1990. The company manufactures a portfolio of generic oral solid-dose drugs—including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine—and distributes through direct sales to wholesalers, distributors, managed care accounts, and retail pharmacies across all 50 U.S. states and Puerto Rico. Carlsbad Technology is a privately held subsidiary of the Taiwan-based YungShin Group, which the company cites as the source of a stated "bridge" between Asian and Americas pharmaceutical markets.

The company's technical footprint centers on a single California campus featuring an FDA-approved, cGMP-compliant manufacturing facility with state-of-the-art equipment controlling production from raw ingredient to finished product. Supporting infrastructure includes temperature- and air-controlled rack storage, a cGMP-compliant sampling booth, restricted quarantine areas for non-conforming materials and returned products, and a warehouse management system (WMS) for inventory and order fulfillment. Carlsbad Technology holds multiple regulatory credentials: cGMP validation achieved in 1998, FDA approval of its manufacturing facility, VAWD (Verified-Accredited Wholesale Distributors) accreditation from the National Association of Boards of Pharmacy recognized in 21 states, and NABD accreditation. Its first ANDA approval was for Diclofenac Sodium Delayed Release Tablets in 1998.

Carlsbad Technology operates three revenue streams: (1) branded-generic pharmaceutical product sales across multiple therapeutic categories, sold on a quote-based, non-publicly-disclosed pricing basis; (2) regulatory advisory services spanning ANDA/DMF submissions, OTC monograph applications, prescription-to-OTC switches, 510(k)/PMA/IDE medical device pathways, dietary supplement NDI/GRAS approvals, and pharmacovigilance; and (3) contract manufacturing, packaging, and warehousing services for third-party partners leveraging its cGMP facility and temperature-controlled logistics. The go-to-market relies on direct enterprise sales supported by website, trade publication, and industry-event presence. Regulatory advisory functions both as a discrete revenue line and as a capability that supports entry of partners' products into the U.S. market.

Carlsbad Technology firmographics

Firmographics
Name
Carlsbad Technology
Legal name
Carlsbad Technology, Inc.
Website
https://carlsbadtech.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
11–50 employees
Short description
Carlsbad Technology is a Carlsbad, California-based generic pharmaceutical manufacturer, distributor, and FDA regulatory advisor serving wholesalers, managed care accounts, and retail pharmacies nationwide. Founded in 1990, it operates as part of Taiwan's YungShin Group with cGMP-compliant, VAWD-accredited facilities.
Ownership category
akta.pro rank

Carlsbad Technology industry classification

Industry
Product category
Generic Pharmaceuticals
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIAJAB
Specialty Pharmaceutical Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYCRAOAHAB
OTC Medicines & Consumer Health Products Distribution
SECONDARYHLAIAJAO
Compounding Ingredient & API Distributors (Pharma Supply)
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

Keywords

  • Generic pharmaceutical manufacturing
  • FDA regulatory consulting
  • CGMP compliant production
  • Pharmaceutical wholesale distribution
  • ANDA drug approval services

Where Carlsbad Technology is headquartered

Location

Headquarters

HQ city
Carlsbad
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Carlsbad Technology business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Generic Pharmaceutical Product Sales: Manufacturing and selling generic pharmaceutical drugs including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in various dosages and packaging configurations.
  2. Regulatory Advisory Services: FDA consulting services including drug approval consultations, regulatory submissions, compliance support, and US agent services for pharmaceutical, diagnostic, biotech, and medical device companies.
  3. Contract Manufacturing: Contract manufacturing services for generic pharmaceuticals and OTC products with cGMP-compliant facilities.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goGeneric pharmaceutical products - quote-based pricing

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Carlsbad Technology product offering

Product offering

Core offering

Carlsbad Technology manufactures, packages, and distributes a portfolio of generic pharmaceutical drugs (capsules and tablets such as Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine) from its cGMP-compliant, FDA-approved facility in Carlsbad, California. The company also offers contract manufacturing for generic and OTC products, VAWD-accredited wholesale distribution with temperature-controlled warehousing, and FDA regulatory advisory/consulting services covering ANDA submissions, OTC monographs, medical devices, and dietary supplements.

Product overview

Carlsbad Technology is a generic pharmaceutical company offering a comprehensive portfolio of generic drugs and pharmaceutical services. The core product is their Generic Pharmaceuticals line including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in various strengths and packaging sizes. The company operates FDA-approved, cGMP-compliant manufacturing facilities and provides regulatory advisory services spanning drug approval consulting, OTC drug advisory, medical device regulatory services, dietary/health supplement approval, and pharmaceutical packaging. Additional services include VAWD-accredited wholesale distribution, warehousing with temperature control and WMS systems, and sales/marketing across all 50 U.S. states and Puerto Rico. The company entered the U.S. generic pharmaceutical market in 1990, with their first ANDA approved in 1998 for Diclofenac Sodium Delayed Release Tablets.

Differentiator

Problem solved

Functional benefit

Products and services

  • Generic Pharmaceuticals (capsules and tablets) A portfolio of generic pharmaceutical drugs including Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine in capsules and tablets across multiple therapeutic categories (anti-infectives, anti-inflammatories, cardiovascular, neurological).
  • FDA Approved Contract Manufacturing Contract manufacturing services using a cGMP-compliant, FDA-approved California facility with state-of-the-art equipment for generic and OTC pharmaceutical production, with rigorous raw material inspection and quality control throughout the manufacturing cycle.
  • FDA Drug Approval Consulting Consulting services for pharmaceutical, diagnostics, biotech, and medical device companies covering ANDA submissions, Drug Master File (DMF) submissions, FDA meeting support, cGMP compliance, and US agent services.
  • FDA OTC Drug Approval Consulting Consulting for over-the-counter drug approval including OTC drug monograph applications, prescription-to-OTC switch applications, and Time and Extent Application (TEA) preparation for OTC Drug Monograph amendments.
  • FDA Medical Devices Regulatory Advisory Regulatory advisory for medical devices covering 510(k) Premarket Notifications, Investigational New Drug Applications (INDs), Investigational Device Exemption Applications (IDEs), Premarket Approval Applications (PMAs), Biologic License Applications (BLA), and 513(g) Requests for Classification.
  • FDA Dietary Supplement Approval Consulting Regulatory consulting for dietary supplements including New Dietary Ingredient (NDI) notifications, GRAS (Generally Recognized as Safe) supplement approvals, regulatory label services, and FDA compliance.
  • FDA Health Supplement Approval Regulatory Advisory Regulatory advisory for health supplements including GMP compliance and audits, label review, cGMP compliance, clinical trials, NDI notifications, documentation, recall assistance, and quality systems.
  • Generic Pharmaceutical Drug Packaging Drug packaging and repackaging services ensuring compliance with FDA guidelines for labeling, container closure, product identity, quality, purity, and contamination prevention, including child-resistant features.
  • Warehousing & Distribution Temperature-controlled warehouse storage with cGMP-compliant sampling booth and quarantine area, utilizing a Warehouse Management System (WMS) for inventory tracking, order fulfillment, and pharmaceutical supply chain management, supporting ambient, hazardous, and refrigerated conditions.
  • VAWD-Accredited Wholesale Distribution Verified-Accredited Wholesale Distributors (VAWD) certified wholesale distribution recognized by 21 U.S. states, ensuring compliance with state and federal laws for distributing prescription drugs from manufacturers to pharmacies.
  • Pharmaceutical Sales & Marketing Sales and marketing of generic pharmaceuticals across all 50 U.S. states and Puerto Rico, with capability to partner with contract developers and manufacturers to market their products.

Quantifiable outcome

  • cGMP validation achieved in 1998, demonstrating long-term compliance capability
  • +2 more outcomes

Companies that use Carlsbad Technology

Customer profile

Named customers4 records

Segments1 record

Ideal customer profiles3 records

Carlsbad Technology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Carlsbad Technology partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • YungShin GroupcoreStrategic or Co-development PartnerCarlsbad Technology, Inc. is part of the worldwide YungShin Group, which provides strength, commitment to innovation, and pursuit of providing the best medicines to enhance human health. YungShin represents world-class quality standards.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Carlsbad Technology competitors and assessment

Company assessment

Broad incumbents

  • Dr. Reddy's Laboratories: India-headquartered global pharmaceutical company with a substantial U.S. generics business. Comparable in cross-border generics supply chain and FDA-approved manufacturing footprint, though materially larger and broader in API and finished dosage portfolio.
  • Endo International: Specialty and generic pharmaceutical manufacturer with a portfolio spanning sterile injectables, generic solids, and branded specialty. A broader incumbent versus Carlsbad Tech, with overlapping generics distribution but a substantially wider therapeutic footprint.
  • Sandoz: Novartis's generic pharmaceutical division with global manufacturing and U.S. distribution. A broad incumbent competing head-to-head with Carlsbad Tech across generic solid orals, injectables, and biosimilars, but at a vastly larger scale.
  • Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with extensive U.S. operations and a broad ANDA portfolio across most therapeutic categories. Comparable as a competitor in the same generic categories Carlsbad Tech serves, but at vastly greater scale and portfolio breadth.

Direct peers

  • Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with a large U.S. subsidiary (Aurobindo Pharma USA) and FDA-approved manufacturing facilities. Comparable to Carlsbad Tech through its foreign-parent-backed U.S. generics distribution model and ANDA-heavy portfolio.
  • Glenmark Pharmaceuticals: India-headquartered generic pharmaceutical company with a U.S. presence (Glenmark Pharmaceuticals Inc., USA). Comparable to Carlsbad Tech as a foreign-owned, U.S.-distributed generic manufacturer serving wholesalers and managed care accounts.
  • Apotex: Canadian-headquartered generic pharmaceutical manufacturer with significant U.S. distribution and a broad ANDA portfolio. Comparable to Carlsbad Tech in generic manufacturing, FDA-approved facility profile, and cross-border supply chain orientation.
  • Upsher-Smith Laboratories: Mid-sized U.S. generic pharmaceutical manufacturer with both branded specialty and generic product lines. Comparable to Carlsbad Tech in target customers, therapeutic categories (cardiovascular, CNS), and contract manufacturing/distribution capabilities.
  • Lannett Company: U.S. generic drug manufacturer with a portfolio spanning solid oral, topical, and specialty generics. Comparable to Carlsbad Tech in business model (generic manufacturer/distributor) and competitive positioning as a smaller U.S. generics player.
  • Amneal Pharmaceuticals: U.S.-focused generic and specialty pharmaceutical manufacturer with an integrated manufacturing and distribution model. Closely comparable to Carlsbad Tech in product mix, ANDA strategy, and mid-tier scale, but materially larger in headcount and portfolio breadth.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Carlsbad Technology social profiles

Digital presence

Carlsbad Technology compliance and trust

Trust signal

Compliance3 records

Carlsbad Technology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Carlsbad Technology leadership team

Management profile

Number of profiles

Profiles1 record

Carlsbad Technology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Carlsbad Technology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carlsbad Technology

What does Carlsbad Technology do?

Carlsbad Technology manufactures, packages, and distributes a portfolio of generic pharmaceutical drugs (capsules and tablets such as Acyclovir, Cefaclor, Ciprofloxacin, Diclofenac Sodium, Entecavir, Famotidine, Felodipine, Glimepiride, Lovastatin, Meloxicam, and Memantine) from its cGMP-compliant, FDA-approved facility in Carlsbad, California. The company also offers contract manufacturing for generic and OTC products, VAWD-accredited wholesale distribution with temperature-controlled warehousing, and FDA regulatory advisory/consulting services covering ANDA submissions, OTC monographs, medical devices, and dietary supplements.

Is Carlsbad Technology a public or private company?

Carlsbad Technology is a private company. It is classified as corporate owned and is currently operating.

When was Carlsbad Technology founded?

Carlsbad Technology was founded in 1990. It employs 11 to 50 people.

Where is Carlsbad Technology based?

Carlsbad Technology is headquartered in Carlsbad, United States, in the North America region.

How does Carlsbad Technology make money?

Three revenue lines are on record. Generic Pharmaceutical Product Sales are the primary driver. The others are regulatory Advisory Services and contract Manufacturing.

Who are Carlsbad Technology's main competitors?

Broad incumbents on record are Dr. Reddy's Laboratories, Endo International, Sandoz and Teva Pharmaceutical Industries. Direct peers are Aurobindo Pharma, Glenmark Pharmaceuticals, Apotex, Upsher-Smith Laboratories, Lannett Company and Amneal Pharmaceuticals.

Does Carlsbad Technology have an API?

No public API is recorded for Carlsbad Technology.

What industry is Carlsbad Technology in?

Carlsbad Technology's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 424210 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales